Mayne Pharma Group Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$605.95 M |
Shares Outstanding |
1.57 B |
Public Float |
- |
Mayne Pharma Group Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.03 |
Market Cap |
AUD846.87 M |
Shares Outstanding |
1.58 B |
Public Float |
1.35 B |
Address |
1538 Main North Road Salisbury South Australia (SA) 5106 Australia |
Employees | - |
Website | http://www.maynepharma.com |
Updated | 07/08/2019 |
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. |